In recent years, a hand full of AI startup companies that managed to utilize AI/ML to discover novel targets and/or design therapeutics reached human clinical trials and received massive media attention. However, there are several similar transformative cases in big pharmaceutical companies.
AI In Big Pharma: The First Antibody Designed Using AI In The Clinic
